These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1614394)

  • 21. Transcriptional regulation of vascular endothelial growth factor by estradiol and tamoxifen in breast cancer cells: a complex interplay between estrogen receptors alpha and beta.
    Buteau-Lozano H; Ancelin M; Lardeux B; Milanini J; Perrot-Applanat M
    Cancer Res; 2002 Sep; 62(17):4977-84. PubMed ID: 12208749
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Angiogenic effect of interleukin-8 in breast cancer and its association with estrogen receptor].
    Lin Y; Wang SM; Huang RP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(20):1419-23. PubMed ID: 16029657
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High ACAT1 expression in estrogen receptor negative basal-like breast cancer cells is associated with LDL-induced proliferation.
    Antalis CJ; Arnold T; Rasool T; Lee B; Buhman KK; Siddiqui RA
    Breast Cancer Res Treat; 2010 Aug; 122(3):661-70. PubMed ID: 19851860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of estrone sulfatase and proliferation of human breast cancer cells by nonsteroidal (p-O-sulfamoyl)-N-alkanoyl tyramines.
    Selcer KW; Hegde PV; Li PK
    Cancer Res; 1997 Feb; 57(4):702-7. PubMed ID: 9044848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Determination of estradiol 2- and 16-alpha-hydroxylase activities in MCF-7 human breast cancer cells in culture using radiometric analysis.
    Niwa T; Bradlow HL; Fishman J; Swaneck GE
    J Steroid Biochem; 1989 Aug; 33(2):311-4. PubMed ID: 2770303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endocrine characteristics of human breast epithelial cells, MCF-10F.
    Singhal H; Guo L; Bradlow HL; Mittelman A; Tiwari RK
    Horm Res; 1999; 52(4):171-7. PubMed ID: 10725782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Catechol estrogen formation in MCF-7 cell culture and effects of bromoestrogen inhibitors.
    Brueggemeier RW; Katlic NE; Palmer CW; Stevens JM
    Mol Cell Endocrinol; 1989 Jul; 64(2):161-7. PubMed ID: 2551756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells.
    Schneider J; Huh MM; Bradlow HL; Fishman J
    J Biol Chem; 1984 Apr; 259(8):4840-5. PubMed ID: 6325410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated estrogen 16 alpha-hydroxylase activity: is this a genotoxic or nongenotoxic biomarker in human breast cancer risk?
    Nebert DW
    J Natl Cancer Inst; 1993 Dec; 85(23):1888-91. PubMed ID: 8230275
    [No Abstract]   [Full Text] [Related]  

  • 31. [Enzymes of estrogen metabolism in breast cancer and their correlation with outcome].
    Shashova EE; Kondakova IV; Slonimskaia EM; Glushchenko SA
    Vopr Onkol; 2011; 57(6):722-6. PubMed ID: 22416387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased estrogen-16 alpha-hydroxylase activity in women with breast and endometrial cancer.
    Fishman J; Schneider J; Hershcope RJ; Bradlow HL
    J Steroid Biochem; 1984 Apr; 20(4B):1077-81. PubMed ID: 6727352
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization.
    Swaneck GE; Fishman J
    Proc Natl Acad Sci U S A; 1988 Nov; 85(21):7831-5. PubMed ID: 3186693
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue content of hydroxyestrogens in relation to survival of breast cancer patients.
    Castagnetta LA; Granata OM; Traina A; Ravazzolo B; Amoroso M; Miele M; Bellavia V; Agostara B; Carruba G
    Clin Cancer Res; 2002 Oct; 8(10):3146-55. PubMed ID: 12374682
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatase regulation and breast cancer.
    Reed MJ; Purohit A
    Clin Endocrinol (Oxf); 2001 May; 54(5):563-71. PubMed ID: 11380485
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of estrogens on MCF-7 cells: positive or negative regulation by the nature of the ligand-receptor complex.
    Swaneck GE; Fishman J
    Biochem Biophys Res Commun; 1991 Jan; 174(1):276-81. PubMed ID: 1989606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Upregulation of estradiol C16 alpha-hydroxylation in human breast tissue: a potential biomarker of breast cancer risk.
    Osborne MP; Bradlow HL; Wong GY; Telang NT
    J Natl Cancer Inst; 1993 Dec; 85(23):1917-20. PubMed ID: 8230281
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adipocyte-derived factor as a modulator of oxidative estrogen metabolism: implications for obesity and estrogen-dependent breast cancer.
    Bradlow HL; Sepkovic DW; Telang N; Tiwari R
    In Vivo; 2011; 25(4):585-8. PubMed ID: 21709000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotransformation of estradiol by explant culture of human mammary tissue.
    Telang NT; Axelrod DM; Wong GY; Bradlow HL; Osborne MP
    Steroids; 1991 Jan; 56(1):37-43. PubMed ID: 2028481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of estrogens and estrogen metabolites in human breast tissue and urine.
    Taioli E; Im A; Xu X; Veenstra TD; Ahrendt G; Garte S
    Reprod Biol Endocrinol; 2010 Aug; 8():93. PubMed ID: 20678202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.